531898 — Sanguine Media Income Statement
0.000.00%
Last trade - 00:00Consumer CyclicalsMicro Cap
Annual income statement for Sanguine Media, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IAS | IAS | IAS | IAS | — |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0 | 0 | 0 | 0.95 | 1.23 |
| Cost of Revenue | |||||
| Gross Profit | 0 | 0 | 0 | -0.659 | -0.3 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 19.7 | 0.496 | 1.51 | 42.8 | 2.82 |
| Operating Profit | -19.7 | -0.496 | -1.51 | -41.9 | -1.6 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -19.2 | -0.068 | -0.181 | -41 | -1.6 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -19.2 | -0.068 | 20.1 | -41 | -1.6 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -19.2 | -0.068 | 20.1 | -41 | -1.6 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -19.2 | -0.068 | 20.1 | -41 | -1.6 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.169 | -0.001 | 0.176 | -0.009 | -0.014 |